LincRoR has been shown to modulate cancer progression via interaction with microRNA-145 [47], and microRNA-145-5p was shown to ameliorate hypertrophic scar through suppression of myofibroblast activation and reduction of Smad2/3 [53]. Here, LINC-ROR is linked to cancer.